Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

The conclusion is that the increasing use of drugs for lifestyle reasons is a complex issue influenced by corporate profit, consumer behavior, and the medicalization of everyday life, with potential negative effects on personal well-being.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Melatonin may help treat PCOS symptoms in rats.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

The most common causes of hair loss in children in South-East Nigeria are fungal infections and alopecia areata.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Men with testicular cancer were less likely to experience baldness and severe acne.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Hormones and genes affect hair growth and male baldness.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Testosterone helps human pancreatic cells increase insulin release.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

A 12-year-old boy with a rare genetic condition has progressive hair loss with no effective treatment.

Modern beauty standards encourage women to remove pubic hair for aesthetic and social reasons.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.